Browse Tag

IPO

Meesho Limited Share Price Today (24 December 2025): Stock Rebounds Near ₹195 After a Wild Post‑IPO Swing — News, Analyst Targets, Forecasts, and What Investors Watch Next

Meesho Limited Share Price Today (24 December 2025): Stock Rebounds Near ₹195 After a Wild Post‑IPO Swing — News, Analyst Targets, Forecasts, and What Investors Watch Next

Meesho Limited (NSE: MEESHO, BSE: 544632) is having the kind of “welcome to public markets” month that makes even seasoned traders reach for the antacids. After a scorching post‑listing run, Meesho stock snapped back sharply over the past week—then staged
Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook

Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook

Meesho Limited (NSE: MEESHO | BSE: 544632) is having the kind of post-IPO week that makes both momentum traders and long-term investors sit up straight: a blistering rally, followed by a sharp, liquid-looking reversal. On December 23, 2025, Meesho shares
7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

DALLAS / TOKYO — December 22, 2025 — 7‑Eleven’s North American business is heading into a major leadership transition just as its Japanese parent, Seven & i Holdings, accelerates a broader turnaround and prepares the groundwork for a future U.S.
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease
Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

December 21, 2025 — Meesho Limited’s stock has become the headline-grabber of India’s late-2025 IPO wave, delivering a blistering post-listing run that’s sparked equal parts excitement and unease on Dalal Street. After debuting on December 10, 2025, Meesho’s shares surged
1 2 3 14
Go toTop